| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/10/2011 | US20110034497 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/10/2011 | US20110034495 Method of Modulating Stress-Activated Protein Kinase System |
| 02/10/2011 | US20110034487 Cxcr3 antagonists |
| 02/10/2011 | US20110034482 Amine salts of a crth2 antagonist |
| 02/10/2011 | US20110034462 Organic compounds |
| 02/10/2011 | US20110034456 Imidazopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034443 Uses of substituted imidazoheterocycles |
| 02/10/2011 | US20110034441 Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof |
| 02/10/2011 | US20110034418 Pharmaceutical composition with bisphosphonate |
| 02/10/2011 | US20110034401 Novel process for solubilizing protein from a proteinaceous material and compositions thereof |
| 02/10/2011 | US20110034392 Hyaluronic Acid and Chondroitin Sulfate Based Hydrolyzed Collagen Type II and Method of Making Same |
| 02/10/2011 | US20110034391 Shaped article |
| 02/10/2011 | US20110034385 Compositions Useful for the Treatment of Diabetes and Other Chronic Disorder |
| 02/10/2011 | US20110033567 Preparation Comprising Mycobacterium Bovis BCG Killed by Extended Freeze Drying (EFD) for Preventing or Treating Rheumatoid Arthritis |
| 02/10/2011 | US20110033552 Apatite/collagen composite powder, formable-to-any-shape artificial bone paste, and their production methods |
| 02/10/2011 | US20110033539 Compositions and methods for preparing and using same |
| 02/10/2011 | US20110033521 Molecules and Methods of Using Same for Treating MCP-1/CCR2 Associated Diseases |
| 02/10/2011 | US20110033516 Methods and compositions for bone healing by periostin |
| 02/10/2011 | US20110033483 Single-chain multivalent binding proteins with effector function |
| 02/10/2011 | US20110033456 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 02/10/2011 | US20110033451 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 02/10/2011 | US20110033443 Method for Increasing Bone Mass |
| 02/09/2011 | EP2281578A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 02/09/2011 | EP2281568A2 Uses of soluble CTLA4 mutant molecules |
| 02/09/2011 | EP2281561A2 Use of LCK inhibitors for treatment of immunologic diseases |
| 02/09/2011 | EP2280934A2 Fatty acid amides and uses thereof |
| 02/09/2011 | EP2280928A2 Vinyl substituted fatty acids |
| 02/09/2011 | EP2280766A1 Carboxamide compounds and their use as chemokine receptor agonists |
| 02/09/2011 | EP2280732A2 Antibodies to granulocyte-macrophage colony-stimulating factor |
| 02/09/2011 | EP1924579B1 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 02/09/2011 | EP1807090B1 Process for the preparation of ibandronate |
| 02/09/2011 | EP1451192B1 Novel crystalline compound |
| 02/09/2011 | EP1379508B9 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 02/09/2011 | EP1370276B1 Intercellular communication facilitating compounds and their medical use |
| 02/09/2011 | CN1827638B Vancomycin and nor-vancomycin derivatives and their preparation process and use |
| 02/09/2011 | CN1732955B Pharmaceutical composition making anemarrhena total sapogenin as active ingredient, its preparation method and use |
| 02/09/2011 | CN101970493A A monoclonal antibody and a method thereof |
| 02/09/2011 | CN101970489A Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 02/09/2011 | CN101970442A Bicyclic pyrrole compound |
| 02/09/2011 | CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors |
| 02/09/2011 | CN101969951A Method of treating arthritis |
| 02/09/2011 | CN101967150A Spiroheterocyclic compounds and their uses as therapeutic agents |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/09/2011 | CN101967117A Substituted pyrrole derivatives and their use as HMG-CO inhibitors |
| 02/09/2011 | CN101966331A Medicament for treating cervical spondylosis and preparation method thereof |
| 02/09/2011 | CN101966316A Gujin pill pellet and preparation method thereof |
| 02/09/2011 | CN101966315A Traditional Chinese medicine for treating bone injury |
| 02/09/2011 | CN101966310A Traditional Chinese medicine for treating lung cancer |
| 02/09/2011 | CN101966304A Medicament for freeing network vessels and activating blood and preparation method thereof |
| 02/09/2011 | CN101966298A Traditional Chinese medicine for treating wind-cold numbness |
| 02/09/2011 | CN101966280A Traditional Chinese medicine for treating diabetes mellitus and gout |
| 02/09/2011 | CN101966279A Traditional Chinese medicine for treating diabetic gout |
| 02/09/2011 | CN101966269A Medicament for treating delayed bone fracture union disease |
| 02/09/2011 | CN101966253A Tao hong si wu granule and preparation method thereof |
| 02/09/2011 | CN101966237A Medicament for treating paralysis and preparation method thereof |
| 02/09/2011 | CN101966233A Preparation method of tuber fleeceflower root formulation granules |
| 02/09/2011 | CN101966222A Medicinal composition and preparation for strengthening bones and preparation method thereof |
| 02/09/2011 | CN101966163A Febuxostat dispersible tablet and preparation method thereof |
| 02/09/2011 | CN101965974A Compositions and products containing enantiomeric equol, and methods for their making |
| 02/09/2011 | CN101703757B Plaster for reuniting fractured tendons and bones and activating blood, and preparation method thereof |
| 02/09/2011 | CN101637549B Medicine for treating fracture |
| 02/09/2011 | CN101384595B Salt of CD 80 antagonist |
| 02/09/2011 | CN101336993B External tincture for treating wind-dampness arthralgia and urgent sprain and preparation method thereof |
| 02/09/2011 | CN101229353B Medicine compounds for treating rheumatoid and atrophic arthritis |
| 02/09/2011 | CN101161251B Teasel root total saponin as well as its extracting method and application |
| 02/08/2011 | US7884092 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/08/2011 | US7883880 DNA polymerase lambda and uses thereof |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | CA2639651C Orally administered peptides to ameliorate atherosclerosis |
| 02/08/2011 | CA2615991C Substituted propanamide derivative and pharmaceutical composition comprising the same |
| 02/08/2011 | CA2494300C Growth hormone releasing peptides |
| 02/08/2011 | CA2464214C Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/08/2011 | CA2442319C Carboxylic acid derivative and salt thereof |
| 02/08/2011 | CA2403900C Substituted chalcones as therapeutic compounds |
| 02/03/2011 | WO2011014825A2 Antiangiogenic small molecules and methods of use |
| 02/03/2011 | WO2011014766A2 Crystallization method and bioavailability |
| 02/03/2011 | WO2011014516A1 Estrogen antagonists as treatments for sclerosing disorders |
| 02/03/2011 | WO2011013785A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | WO2011013359A1 Medicinal composition for iontophoresis |
| 02/03/2011 | WO2011012526A1 Flavanones-containing food compositions |
| 02/03/2011 | WO2010124276A3 Anti-tgf-beta induction of bone cell function and bone growth |
| 02/03/2011 | WO2010118298A3 Compositions and methods for bioactive coatings to improve allograft incorporation |
| 02/03/2011 | US20110028542 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof |
| 02/03/2011 | US20110028523 Selective Alpha 2B/2C Agonists |
| 02/03/2011 | US20110028522 Fullerene therapies for inflammation |
| 02/03/2011 | US20110028509 Sulfonamides |
| 02/03/2011 | US20110028507 Pyridine derivatives and methods of use thereof |
| 02/03/2011 | US20110028489 Pyrimidine Derivatives and Their Use for Treating Bone-Related Disorders |
| 02/03/2011 | US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/03/2011 | US20110028455 Indole-substituted 3-cyanopyridines As Kinase Inhibitors |
| 02/03/2011 | US20110028454 Deuterium-enriched bazedoxifene |
| 02/03/2011 | US20110028452 PYRIDO[4,3-d]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS |
| 02/03/2011 | US20110028449 Novel aminomethyl benzene derivatives |
| 02/03/2011 | US20110028435 Crystallization method and bioavailability |
| 02/03/2011 | US20110028428 Hirsutella sinensis mycelia compositions and methods for treating sepsis and related inflammatory responses |
| 02/03/2011 | US20110028416 Nutritional compositions for promotion of bone growth and maintenance of bone health comprising extracts of for example rosemary or caraway |
| 02/03/2011 | US20110028400 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair |
| 02/03/2011 | US20110028398 Methods for treating and limiting fibrotic disorders and keloids |
| 02/03/2011 | US20110028393 Flowable paste and putty bone void filler |